Table of Contents
Good Manufacturing Practice (GMP) is an important part of pharmaceutical quality assurance. It helps ensure that medicines are consistently produced and controlled according to appropriate quality standards.
WHO-GMP and EU-GMP both focus on pharmaceutical manufacturing quality, but they operate within different regulatory frameworks and market requirements. For pharmaceutical exporters and buyers, understanding these differences can help with supplier evaluation, compliance planning, and international business requirements.
1. What Is GMP and Why Is It Important?
Good Manufacturing Practice is a quality system designed to help ensure that pharmaceutical products are consistently produced and controlled according to defined quality standards.
GMP covers areas such as:
- Manufacturing processes
- Quality control
- Personnel
- Premises and equipment
- Documentation
- Validation
- Quality risk management
- Complaints and product handling
The purpose is to reduce risks such as contamination, mix-ups, incorrect labelling, and inconsistent product quality.
2. What Is WHO-GMP?
WHO-GMP refers to Good Manufacturing Practice guidelines developed by the World Health Organization.
According to WHO, Good Manufacturing Practices (GMP) are the part of Quality Assurance (QA) that ensures pharmaceutical products are consistently produced and controlled according to quality standards appropriate to their intended use and as required by the marketing authorization.
In practical terms, WHO-GMP is a quality system requirement ensuring that pharmaceutical products are consistently manufactured, tested, documented, stored and controlled in accordance with approved specifications and applicable quality standards.
Main areas covered by WHO-GMP
- Quality Management / Quality Assurance
- Personnel
- Premises and equipment
- Documentation and records
- Production
- Quality Control
- Sanitation and hygiene
- Qualification and validation
- Complaints and product recalls
- Self-inspection/internal audits
- Contract manufacture and analysis
- Handling of deviations and investigations
- Change control
- Storage and distribution
- Prevention of contamination and mix-ups
3. What Is EU-GMP?
EU-GMP stands for European Union Good Manufacturing Practice. It is the GMP framework established by the European Union for the manufacture and control of medicinal products.
The main official reference is EudraLex Volume 4 - EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use. The European Commission states that Volume 4 contains the applicable legislation and guidance for interpreting the principles and guidelines of GMP.
Major areas of EU-GMP
For human medicinal products, EudraLex Volume 4 Part I contains nine main chapters.
- Chapter 1 - Pharmaceutical Quality System (PQS)
- Chapter 2 - Personnel
- Chapter 3 - Premises and Equipment
- Chapter 4 - Documentation
- Chapter 5 - Production
- Chapter 6 - Quality Control
- Chapter 7 - Outsourced Activities
- Chapter 8 - Complaints and Product Recall
- Chapter 9 - Self Inspection
4. WHO-GMP vs EU-GMP: Key Differences
| Area | WHO-GMP | EU-GMP |
|---|---|---|
| Regulatory context | International WHO framework used by many countries | European Union regulatory framework |
| Main purpose | Supports consistent pharmaceutical quality and international GMP implementation | Supports GMP compliance within the EU regulatory system |
| Quality systems | Covers pharmaceutical quality assurance and manufacturing controls | Includes detailed Pharmaceutical Quality System requirements |
| Documentation | Requires appropriate documented procedures and records | Detailed documentation requirements are included within EudraLex Volume 4 |
| Inspections | Used by national authorities and in WHO-related quality systems | Inspections are conducted within EU regulatory frameworks |
| International applicability | Very broad; used as a global GMP reference | Primarily EU/EEA regulatory framework, although widely accepted internationally |
| Production controls | Defined procedures, controls and in-process monitoring | Similar, but generally more detailed and prescriptive |
| Batch release | National regulatory framework applies | Qualified Person (QP) certification and batch release are major EU requirements |
These frameworks share many fundamental GMP principles, but specific regulatory expectations can differ depending on the market, product, and applicable legislation.
5. Manufacturing Quality & Documentation
Both WHO-GMP and EU-GMP place strong importance on controlled manufacturing processes and reliable documentation.
Manufacturers may need documented systems covering:
- Standard operating procedures
- Batch manufacturing records
- Quality control testing
- Equipment qualification
- Process validation
- Cleaning procedures
- Deviation management
- Corrective and preventive actions
- Change control
- Complaint and recall procedures
EU-GMP specifically organizes requirements across areas including pharmaceutical quality systems, personnel, premises, documentation, production, quality control, outsourced activities, complaints and recalls, and self-inspection.
6. Inspections & Buyer Considerations
GMP compliance involves more than holding a certificate. Buyers and business partners may also consider the manufacturer's quality systems, inspection history, manufacturing capabilities, documentation, product approvals, and regulatory status.
Before selecting a pharmaceutical manufacturing or export partner, buyers may review:
- GMP certification or authorization
- Manufacturing site details
- Product quality documentation
- Regulatory approvals
- Quality control capabilities
- Inspection or compliance information
- Country-specific requirements
The exact documents and compliance expectations depend on the destination market and pharmaceutical product.
7. How to Choose the Right GMP Requirement
There is no single GMP framework that is universally applicable to every pharmaceutical export.
The appropriate requirements depend on:
- Destination country
- Product type
- Intended market
- Registration requirements
- Importing country's regulations
- Buyer or tender requirements
Exporters should confirm the applicable requirements before entering a new market and work with qualified regulatory or compliance professionals when necessary.
8. Frequently Asked Questions
What is WHO-GMP?
What is EU-GMP?
Is WHO-GMP and EU-GMP the same?
Is EU-GMP required for every pharmaceutical export?
What should pharmaceutical buyers check?
9. Conclusion
WHO-GMP and EU-GMP both support pharmaceutical quality, safety, and consistent manufacturing, but they operate within different regulatory contexts.
For pharmaceutical exporters and B2B buyers, the important consideration is not simply choosing one framework over another. The relevant GMP requirements should be evaluated according to the destination market, product, regulatory pathway, and buyer requirements.
Understanding these frameworks can help pharmaceutical companies prepare appropriate documentation, evaluate manufacturing partners, and plan international market entry more effectively.